{
    "nct_id": "NCT06703437",
    "official_title": "A Phase I Open Label Peri-prostatic Neuraxial Block with Lidocaine and Ethanol in High-risk Localized Prostate Cancer",
    "inclusion_criteria": "* PSA >10\n* PSAD >0.15\n* PI-RADS 5 lesion on MRI\n* Karnofsky performance status >80\n* Ability to understand and the willingness to sign a written informed consent.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 45 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Prior or concomitant treatment for prostate cancer, including radiation therapy, focal therapy, cryo therapy, androgen deprivation therapy.\n* Imaging or clinical evidence of metastatic disease.\n* PSA > 100ng/mL",
    "miscellaneous_criteria": ""
}